85.14 -0.22 -0.26%
After-market 04:00:59 PM EDT 7/19/2024 BTT
Plus500. 80% of retail CFD accounts lose money
85.36 +0.08 +0.09%
Official Close 03:59:59 PM EDT 7/19/2024 BTT

On Thursday 07/18/2024 the closing price of the Healthsouth Corp Registered Shs share was $85.36 on BTT. Compared to the opening price on Thursday 07/18/2024 on BTT of $85.64, this is a drop of 0.33%. Healthsouth Corp Registered Shs's market capitalization is $8.60 B by 100.69 M shares outstanding.
Is Healthsouth stock a Buy, Sell or Hold? Healthsouth stock has received a consensus rating of buy. The average rating score is and is based on 30 buy ratings, 8 hold ratings, and 0 sell ratings.
What was the 52-week low for Healthsouth stock? The low in the last 52 weeks of Healthsouth stock was 58.43. According to the current price, Healthsouth is 145.71% away from the 52-week low.
What was the 52-week high for Healthsouth stock? The high in the last 52 weeks of Healthsouth stock was 88.21. According to the current price, Healthsouth is 96.52% away from the 52-week high.
What are analysts forecasts for Healthsouth stock? The 38 analysts offering price forecasts for Healthsouth have a median target of 78.50, with a high estimate of 113.00 and a low estimate of 57.00. The median estimate represents a 108.46 difference from the last price of 85.14.

Healthsouth Stock Snapshot

57.62
Bid
1.00
Bid Size
85.54
Ask
3.00
Ask Size
7/19/2024
Date
4:00 PM
Time
0.00
Volume
85.36
Prev. Close
0.00
Open
100.69 M
Number of Shares
58.43
52 Week Low
88.21
52 Week High
85.14
0.60
Dividend in USD
0.90
Dividend Yield
19.20
P/E Ratio
98.47
Free Float in %
3.51
EPS in USD
16.43
Book Value per Share in USD
8.40
Cash Flow per Share in USD

Historical Prices for Healthsouth

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Healthsouth Analyst Data

Total Analysts: 38
Buy Ratings: 30 Neutral Ratings: 8 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 57.00 Median: 78.50 Highest: 113.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Healthsouth Analyst Opinions

Date Analyst Rating Price
07/10/24 Barclays Capital
Maintained Buy $113
06/05/24 Stephens Inc.
Maintained Buy $94
05/22/24 RBC Capital Markets
Maintained Buy $95
04/26/24 Raymond James Financial, Inc.
Maintained Buy $95
04/25/24 Barclays Capital
Maintained Buy $108
04/25/24 Mizuho
Maintained Buy $95
03/28/24 Barclays Capital
Maintained Buy $101
03/06/24 Barclays Capital
Maintained Buy $95
02/09/24 RBC Capital Markets
Maintained Buy $83
02/09/24 Mizuho
Maintained Buy $82
01/16/24 Stephens Inc.
Maintained Buy $85
09/28/23 RBC Capital Markets
Maintained Buy CAD83
08/08/23 RBC Capital Markets
Maintained Buy $83
08/04/23 Credit Suisse
Maintained Buy $80
08/03/23 Raymond James Financial, Inc.
Maintained Buy $85
08/03/23 Mizuho
Maintained Buy $77
08/03/23 Barclays Capital
Maintained Hold $71
07/20/23 Stephens Inc.
Maintained Buy $78
06/29/23 Stephens Inc.
Maintained Buy $78
05/02/23 RBC Capital Markets
Maintained Buy $70
05/02/23 Raymond James Financial, Inc.
Maintained Buy $80
05/01/23 Deutsche Bank
Maintained Buy $73
05/01/23 Stephens Inc.
Maintained Buy $74
05/01/23 Credit Suisse
Maintained Buy $76
05/01/23 Mizuho
Maintained Buy $74
04/28/23 Bank of America Merrill Lynch
Maintained Buy $74
04/04/23 Barclays Capital
Maintained Hold $61
03/14/23 Barclays Capital
Maintained Hold $57
02/09/23 Credit Suisse
Maintained Buy $73
02/09/23 Mizuho
Maintained Buy $69
02/08/23 Stephens Inc.
Maintained Buy $70
10/28/22 Stephens Inc.
Maintained Buy $58
10/28/22 Raymond James Financial, Inc.
Maintained Buy $72
09/21/22 Credit Suisse
Maintained Buy $62
08/24/22 RBC Capital Markets
Maintained Buy $66
08/04/22 BMO Capital Markets
Maintained Buy $65
08/04/22 Raymond James Financial, Inc.
Maintained Buy $65
08/04/22 Barclays Capital
Maintained Buy $63

Healthsouth Estimates* in USD

  2024 2025 2026 2027 2028
Revenue 5,307 5,777 6,280 6,660 7,150
Dividend 0.60 0.60 0.40 - -
Dividend Yield (in %) 0.70 % 0.70 % 0.47 % - -
EPS 4.11 4.59 5.08 4.94 5.19
P/E Ratio 20.69 18.53 16.75 17.23 16.40
EBIT 747 821 898 902 970
EBITDA 1,055 1,147 1,252 1,278 1,357
Net Profit 405 454 515 573 624
Net Profit Adjusted 405 454 515 573 624
Pre-Tax Profit 651 725 779 774 843
Net Profit (Adjusted) 619 700 792 - -
EPS (Non-GAAP) ex. SOE 4.11 4.59 5.08 4.94 5.19
EPS (GAAP) 4.27 4.75 5.21 4.94 5.19
Gross Income - - - - -
Cash Flow from Investing -164 -166 -135 -73 -76
Cash Flow from Operations 821 864 931 994 1,057
Cash Flow from Financing -164 -166 -135 -73 -76
Cash Flow per Share 8.03 8.92 9.33 - -
Free Cash Flow 333 356 400 241 267
Free Cash Flow per Share 3.56 3.77 3.76 2.08 2.22
Book Value per Share 23.94 28.91 34.55 - -
Net Debt 2,479 2,278 2,083 2,301 2,110
Research & Development Exp. - - - - -
Capital Expenditure 578 601 678 753 790
Selling, General & Admin. Exp. 2,930 3,150 3,406 - -
Shareholder’s Equity 2,269 2,679 3,261 3,371 3,975
Total Assets 6,496 6,951 7,674 8,388 9,161
  Previous Quarter
ending 06/30/24
Current Quarter
ending 09/30/24
Next Quarter
ending 12/31/24
Current Year
ending 12/31/24
Next Year
ending 12/31/25
Earnings Estimates
No. of Analysts 12 12 12 12 12
Average Estimate 1.014 USD 0.955 USD 1.020 USD 4.114 USD 4.595 USD
Year Ago 0.913 USD 0.857 USD 0.880 USD 3.514 USD -
Publish Date 8/5/2024 10/23/2024 2/5/2025 - -
Revenue Estimates
No. of Analysts - - - 11 11
Average Estimate - - - 5,307 USD 5,777 USD
Year Ago - - - 4,801 USD -
Publish Date - - - - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2023 2022 2021 2020 2019 2018 2017
Sales 4,801.20 4,348.60 5,121.60 4,644.40 4,605.00 4,277.30 3,919.00
Change of sales in % 10.41 -15.09 10.27 0.86 7.66 9.14 7.49
Gross profit on sales 933.50 784.50 1,003.80 803.30 939.50 901.80 821.10
Gross profit on sales change in % 18.99 -21.85 24.96 -14.50 4.18 9.83 4.72
Operating income 731.80 630.20 806.50 647.80 692.50 681.60 649.40
Operating income change in % 16.12 -21.86 24.50 -6.45 1.60 4.96 0.09
Income before tax 607.20 450.80 657.20 472.60 562.30 493.20 496.40
Income before tax change in % 34.69 -31.41 39.06 -15.95 14.01 -0.64 2.99
Income after tax 349.60 269.80 410.40 283.20 357.40 291.40 255.50
Income after tax change in % 29.58 -34.26 44.92 -20.76 22.65 14.05 3.53

Balance Sheet in Mio. USD

2023 2022 2021 2020 2019 2018 2017
Total liabilities 3,805.20 3,774.60 4,465.70 4,444.30 4,148.00 3,356.30 3,248.20
Long-term liabilities per share 31.41 32.06 37.36 37.49 34.76 27.13 27.78
Equity 2,297.20 1,861.90 2,399.20 2,001.60 1,932.70 1,818.70 1,645.50
Equity change in % 25.73 -31.44 20.36 17.44 5.91 8.04 60.58
Balance sheet total 6,102.40 5,636.50 6,864.90 6,445.90 6,080.70 5,175.00 4,893.70
Balance sheet total change in % 8.27 -17.89 6.50 6.01 17.50 5.75 4.52

Key Data in USD

2023 2022 2021 2020 2019 2018 2017
Sales per share 47.40 43.31 51.11 46.54 46.33 42.86 39.47
P/E ratio (year end quote, basic EPS) 19.20 22.16 15.86 29.04 19.20 21.07 18.37
P/E ratio (year end quote, diluted EPS) 19.20 22.16 15.86 29.04 19.20 21.07 18.37
P/E ratio (year end quote) 19.20 22.16 15.86 29.04 19.20 21.07 18.37
Dividend yield in % 0.90 1.44 1.72 1.35 1.59 1.69 1.98
Equity ratio in % 27.00 23.25 27.84 24.64 22.24 24.67 24.15
Debt ratio in % 62.36 66.97 65.05 68.95 68.22 64.86 66.38

Healthsouth Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Reidy Christopher R 07/15/2024 426.00 11,863.00 86.63 Buy No
Christie Edward M III 07/15/2024 334.00 4,122.00 86.80 Buy No
Reidy Christopher R 07/14/2024 16.00 11,437.00 n/a Buy No
Maryland Patricia Anne 07/14/2024 24.00 13,244.00 n/a Buy No
Williams Terrance 07/14/2024 24.00 13,598.00 n/a Buy No
SCHLICHTING NANCY M 07/14/2024 35.00 19,624.00 n/a Buy No
KATZ LESLYE G 07/14/2024 80.00 45,941.00 n/a Buy No
CARMICHAEL GREG D 07/14/2024 24.00 17,074.00 n/a Buy No
O'Connor Kevin J. 07/14/2024 13.00 8,401.00 n/a Buy No
HERMAN JOAN E 07/14/2024 80.00 45,941.00 n/a Buy No
Christie Edward M III 07/14/2024 6.00 3,788.00 n/a Buy No
Charbonneau Elissa Joy 05/23/2024 10,000.00 18,594.06 85.02 Sell No
Darby John Patrick 05/05/2024 14,543.00 84,773.00 83.94 Sell No
Darby John Patrick 05/05/2024 14,543.00 99,316.00 29.06 Buy No
CARMICHAEL GREG D 05/02/2024 2,000.00 17,050.00 83.73 Buy No
Maryland Patricia Anne 05/01/2024 1,978.00 13,220.00 n/a Buy No
Williams Terrance 05/01/2024 1,978.00 13,574.00 n/a Buy No
KATZ LESLYE G 05/01/2024 1,978.00 45,861.00 n/a Buy No
Tarr Mark J 04/29/2024 44,976.00 554,098.00 83.27 Sell No
Tarr Mark J 04/29/2024 19,460.00 573,558.00 35.83 Buy No
Tarr Mark J 04/29/2024 25,516.00 599,074.00 29.06 Buy No
Reidy Christopher R 04/15/2024 411.00 9,443.00 79.56 Buy No
Christie Edward M III 04/15/2024 314.00 1,804.00 79.65 Buy No
CHIDSEY JOHN 04/15/2024 234.00 162,826.00 79.52 Buy No
Reidy Christopher R 04/14/2024 13.00 9,032.00 n/a Buy No

Healthsouth Dividend Calendar

Date Name Dividend *yield Currency
2023 Healthsouth Corp Registered Shs 0.60 0.90 USD
2022 Healthsouth Corp Registered Shs 0.86 1.44 USD
2021 Healthsouth Corp Registered Shs 1.12 1.72 USD
2020 Healthsouth Corp Registered Shs 1.12 1.35 USD
2019 Healthsouth Corp Registered Shs 1.10 1.59 USD
2018 Healthsouth Corp Registered Shs 1.04 1.69 USD
2017 Healthsouth Corp Registered Shs 0.98 1.98 USD
2016 Healthsouth Corp Registered Shs 0.94 2.28 USD
2015 Healthsouth Corp Registered Shs 0.88 2.53 USD
2014 Healthsouth Corp Registered Shs 0.78 2.03 USD
2013 Healthsouth Corp Registered Shs 0.36 1.08 USD
2012 Healthsouth Corp Registered Shs 0.00 0.00 USD
2011 Healthsouth Corp Registered Shs 0.00 0.00 USD
2010 Healthsouth Corp Registered Shs 0.00 0.00 USD
2009 Healthsouth Corp Registered Shs 0.00 0.00 USD
*Yield of the Respective Date

Healthsouth Corp Registered Shs Calendar

Event Estimate Info Date
Earnings Report 1.014 USD Q2 2024 Earnings Release 08/05/2024
Earnings Report 0.955 USD Q3 2024 Earnings Release 10/23/2024
Earnings Report 1.020 USD Q4 2024 Earnings Release 02/05/2025
Earnings Report 1.216 USD Q1 2025 Earnings Release 04/23/2025
Earnings Report 1.159 USD Q2 2025 Earnings Release 08/05/2025

Healthsouth Corp Registered Shs Past Events

Event Actual EPS Info Date
Annual General Meeting - Annual General Meeting 05/02/2024

Healthsouth Profile

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL. .

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
7
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Healthsouth Shareholder

Owner in %
Freefloat 98.47
The Vanguard Group, Inc. 10.05
Vanguard Group, Inc. (Subfiler) 9.96
Wellington Management Co. LLP 8.16
Wellington Management Co. LLP (Wellington Breakout) 7.35
BlackRock Fund Advisors 5.24
William Blair Investment Management LLC 5.18
William Blair Investment Management LLC 4.05
Invesco Advisers, Inc. 3.43
Vanguard Total Stock Market ETF 3.15
iShares Core S&P Mid Cap ETF 3.11
BlackRock Institutional Trust Co. NA 3.04
State Street Corp. 2.96
The Baupost Group LLC 2.93
Vanguard Small Cap Index Fund 2.51
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.